Here are relevant reports on : attention-deficit-hyperactivity-disorder-therapeutics-market
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029
The global peptide synthesis market, valued at US$0.78 billion in 2023, stood at US$0.81 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$1.41 billion by the end of the period. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User (Hospital, Home Healthcare]-Global Forecast to 2031
The medical gas and equipment market, valued at USD 19.90 billion in 2024, stood at USD 21.03 billion in 2025 and is projected to advance at a resilient CAGR of 6.2% from 2025 to 2031, culminating in a forecasted valuation of US$30.05 billion by the end of the period. The medical gas and equipment market is witnessing constant growth as a result of the rising demand for advanced healthcare services through hospitals, clinics, and homecare settings.
- Published: April 2026
- Price: $ 7150
- TOC Available:
-
mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Research Settings) - Global Forecast to 2027
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Oxygen Concentrators Market by Type (Portable, Stationary), Technology (Continuous and Pulse Flow), Flowrate (0-5L/Min, 5-10L/Min, Above 10L/Min), Application (Chronic Obstructive Pulmonary Disorder), End User (Home Care Settings) - Global Forecast to 2030
The global oxygen concentrators market, valued at US$1.20 billion in 2024, stood at US$1.27 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.71 billion by the end of the period. Air pollution and smoking drive up demand for oxygen concentrators due to their role in worsening respiratory diseases like COPD and asthma, especially in urban and industrial areas.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Legal Marijuana Market by Strain Type ( Cannabis Indica, Cannabis Sativa ), Product ( Dried Cannabis, Oils, Capsules and Others ), Indication ( Chronic Pain, Arthritis, Neurological Disorder, Cancer and Other Indications ), Distribution Channel ( Hospital Pharmacy, Dispensaries and E-commerce ) and Region ( North America, Europe, Asia-Pacific, and LATAM & MEA )- Global Forecast to 2023
Cannabis, also known as marijuana, is a plant that is known for its psychoactive, medicinal, and fibrous properties. Medical cannabis has been proven effective in treating various medical conditions such as chronic pain, arthritis, seizure disorders, Crohn’s disease, and Parkinson’s disease; it is also found to be effective in reducing nausea caused due to chemotherapy, stimulating appetite in AIDs patients, controlling muscular spasms caused by multiple sclerosis, and reducing intraocular pressure in patients suffering from glaucoma.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024
The leukemia therapeutics market is projected to reach USD 17.1 billion by 2024, at a CAGR of 6.8%. Market growth is largely driven by the rising prevalence of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) and increasing approvals of novel & innovative drugs and immunotherapies. The major players in this market are AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland, F. Hoffmann-La Roche (Switzerland), Pfizer (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Takeda Pharmaceutical (Japan), and Celgene (US). Product approvals are a key strategy adopted by key players in order to enhance their dominance in this market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
